Literature DB >> 22410685

Differences in the causes of death of HIV-positive patients in a cohort study by data sources and coding algorithms.

Victoria Hernando1, Paz Sobrino-Vegas, M Carmen Burriel, Juan Berenguer, Gemma Navarro, Ignacio Santos, Jesús Reparaz, M Angeles Martínez, Antonio Antela, Félix Gutiérrez, Julia del Amo.   

Abstract

OBJECTIVES: To compare causes of death (CoDs) from two independent sources: National Basic Death File (NBDF) and deaths reported to the Spanish HIV Research cohort [Cohort de adultos con infección por VIH de la Red de Investigación en SIDA CoRIS)] and compare the two coding algorithms: International Classification of Diseases, 10th revision (ICD-10) and revised version of Coding Causes of Death in HIV (revised CoDe).
METHODS: Between 2004 and 2008, CoDs were obtained from the cohort records (free text, multiple causes) and also from NBDF (ICD-10). CoDs from CoRIS were coded according to ICD-10 and revised CoDe by a panel. Deaths were compared by 13 disease groups: HIV/AIDS, liver diseases, malignancies, infections, cardiovascular, blood disorders, pulmonary, central nervous system, drug use, external, suicide, other causes and ill defined.
RESULTS: There were 160 deaths. Concordance for the 13 groups was observed in 111 (69%) cases for the two sources and in 115 (72%) cases for the two coding algorithms. According to revised CoDe, the commonest CoDs were HIV/AIDS (53%), non-AIDS malignancies (11%) and liver related (9%), these percentages were similar, 57, 10 and 8%, respectively, for NBDF (coded as ICD-10). When using ICD-10 to code deaths in CoRIS, wherein HIV infection was known in everyone, the proportion of non-AIDS malignancies was 13%, liver-related accounted for 3%, while HIV/AIDS reached 70% due to liver-related, infections and ill-defined causes being coded as HIV/AIDS.
CONCLUSION: There is substantial variation in CoDs in HIV-infected persons according to sources and algorithms. ICD-10 in patients known to be HIV-positive overestimates HIV/AIDS-related deaths at the expense of underestimating liver-related diseases, infections and ill defined causes. CoDe seems as the best option for cohort studies.

Entities:  

Mesh:

Year:  2012        PMID: 22410685     DOI: 10.1097/QAD.0b013e328352ada4

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  14 in total

1.  Collaborative, pooled and harmonized study designs for epidemiologic research: challenges and opportunities.

Authors:  Catherine R Lesko; Lisa P Jacobson; Keri N Althoff; Alison G Abraham; Stephen J Gange; Richard D Moore; Sharada Modur; Bryan Lau
Journal:  Int J Epidemiol       Date:  2018-04-01       Impact factor: 7.196

2.  Ten-year Survival by Race/Ethnicity and Sex Among Treated, HIV-infected Adults in the United States.

Authors:  Catherine R Lesko; Stephen R Cole; William C Miller; Daniel Westreich; Joseph J Eron; Adaora A Adimora; Richard D Moore; W Christopher Mathews; Jeffrey N Martin; Daniel R Drozd; Mari M Kitahata; Jessie K Edwards; Michael J Mugavero
Journal:  Clin Infect Dis       Date:  2015-03-12       Impact factor: 9.079

3.  Causes of death in HIV-infected patients from the Cologne-Bonn cohort.

Authors:  K Ehren; C Hertenstein; T Kümmerle; J J Vehreschild; J Fischer; D Gillor; C Wyen; C Lehmann; O A Cornely; N Jung; S Gravemann; M Platten; J C Wasmuth; J K Rockstroh; C Boesecke; C Schwarze-Zander; G Fätkenheuer
Journal:  Infection       Date:  2013-10-01       Impact factor: 3.553

4.  Effect of Immediate Initiation of Antiretroviral Treatment in HIV-Positive Individuals Aged 50 Years or Older.

Authors:  Sara Lodi; Dominique Costagliola; Caroline Sabin; Julia Del Amo; Roger Logan; Sophie Abgrall; Peter Reiss; Ard van Sighem; Sophie Jose; Jose-Ramon Blanco; Victoria Hernando; Heiner C Bucher; Helen Kovari; Ferran Segura; Juan Ambrosioni; Charalambos A Gogos; Nikos Pantazis; Francois Dabis; Marie-Anne Vandenhende; Laurence Meyer; Rémonie Seng; M John Gill; Hartmut Krentz; Andrew N Phillips; Kholoud Porter; Beatriz Grinsztejn; Antonio G Pacheco; Roberto Muga; Janet Tate; Amy Justice; Miguel A Hernán
Journal:  J Acquir Immune Defic Syndr       Date:  2017-11-01       Impact factor: 3.731

5.  Predictors of immunodeficiency-related death in a cohort of low-income people living with HIV: a competing risks survival analysis.

Authors:  M F P M Albuquerque; D N Alves; C C Bresani Salvi; J D L Batista; R A A Ximenes; D B Miranda-Filho; H R L Melo; M Maruza; U R Montarroyos
Journal:  Epidemiol Infect       Date:  2017-01-09       Impact factor: 4.434

6.  Overall and cause-specific excess mortality in HIV-positive persons compared with the general population: Role of HCV coinfection.

Authors:  Belén Alejos; Victoria Hernando; Jose Iribarren; Juan Gonzalez-García; Asuncion Hernando; Jesus Santos; Victor Asensi; Ana Gomez-Berrocal; Julia Del Amo; Inma Jarrin
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

7.  Estimating a Set of Mortality Risk Functions with Multiple Contributing Causes of Death.

Authors:  Tiffany L Breger; Jessie K Edwards; Stephen R Cole; Michael Saag; Peter F Rebeiro; Richard D Moore; Joseph J Eron
Journal:  Epidemiology       Date:  2020-09       Impact factor: 4.860

8.  Incidence of liver damage of uncertain origin in HIV patients not co-infected with HCV/HBV.

Authors:  Antonio Rivero-Juárez; Angela Camacho; Nicolás Merchante; Inés Pérez-Camacho; Juan Macias; Carmen Ortiz-Garcia; Celia Cifuentes; Julián Torre-Cisneros; José Peña; Juan A Pineda; Antonio Rivero
Journal:  PLoS One       Date:  2013-07-18       Impact factor: 3.240

9.  Association of self-reported race with AIDS death in continuous HAART users in a cohort of HIV-infected women in the United States.

Authors:  Kerry Murphy; Donald R Hoover; Qiuhu Shi; Mardge Cohen; Monica Gandhi; Elizabeth T Golub; Deborah R Gustafson; Celeste Leigh Pearce; Mary Young; Kathryn Anastos
Journal:  AIDS       Date:  2013-09-24       Impact factor: 4.177

10.  Oxidative Stress Predicts All-Cause Mortality in HIV-Infected Patients.

Authors:  Mar Masiá; Sergio Padilla; Marta Fernández; Carmen Rodríguez; Ana Moreno; Jose A Oteo; Antonio Antela; Santiago Moreno; Julia Del Amo; Félix Gutiérrez
Journal:  PLoS One       Date:  2016-04-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.